欢迎访问本网站

分子影像与微创诊疗技术实验室

首页 > 新闻内容

CuInS₂/ZnS Quantum Dots Conjugating Gd(III) Chelates for Near-Infrared Fluorescence and Magnetic Resonance Bimodal Imaging

发布日期:2017-07-03 08:13:21

Abstract

A bimodal contrast nanoagent was developed by chelating gadolinium ions to 2-[bis[2-[carboxymethyl-[2-oxo-2-(2-sulfanylethyl-amino)ethyl]amino]ethyl]amino]acetic acid (DTDTPA)-modified CuInS/ZnS quantum dots (QDs). The longitudinal relaxivity (r1) of the resulted QDs@DTDTPA-Gd nanoparticles (NPs) was calculated to be 9.91 mMs-¹, which was 2.5 times as high as that of clinically approved Gd-DTPA (3.9 mM-¹ s-¹). In addition, the in vivo imaging experiments showed that QDs@DTDTPA-Gd NPs could enhance both near-infrared fluorescence and T1-weighted magnetic resonance (MR) imaging of tumor tissue through passive targeting accumulation. Moreover, the high colloidal and fluorescence stabilities and good biocompatibility indicate that QDs@DTDTPA-Gd NPs have a great potential for use as an efficient nanoagent to integrate the extremely high sensitivity of fluorescence imaging to the high resolution of MR imaging. Integration of bimodal detectability in the same agent of QDs@DTDTPA-Gd NPs can avoid extra stress on the blood clearance mechanisms as the administration of multiple dose of agents.

Authors: Yongbo Yang, Li Lin, Lijia Jing, Xiuli Yue* and Zhifei Dai*

Published in ACS Applied Materials & Interfaces28 June, 2017

See full text: http://pubs.acs.org/doi/abs/10.1021%2Facsami.7b05867

招生招聘 | 人才培养 | 联系我们
版权所有©分子影像与微创治疗技术实验室
地址:北京市海淀区颐和园路5号北京大学院内 邮编:100871
电话:010-62767059 邮箱: